Zobrazeno 1 - 10
of 2 880
pro vyhledávání: '"Brems, H."'
Autor:
A.-M. Musschoot
Publikováno v:
BMGN: Low Countries Historical Review, Vol 117, Iss 2 (2002)
Externí odkaz:
https://doaj.org/article/85e53222c0f844c9881f01609c5ab864
Autor:
Galiatsatos P; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA; Office of Diversity, Inclusion, and Health Equity, Johns Hopkins Health System, Baltimore, MD, USA. Electronic address: pgaliat1@jhmi.edu., Brems H; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA., Myers CN; Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA., Montemayor K; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Publikováno v:
Critical care clinics [Crit Care Clin] 2024 Oct; Vol. 40 (4), pp. 741-752. Date of Electronic Publication: 2024 Jul 02.
Autor:
Loverix L., Vergote I., Busschaert P., Vanderstichele A., Venken T., Boeckx B., Harter P., Brems H., Van Nieuwenhuysen E., Pignata S., Baert T., Gonzalez-Martin A., Han S., Marth C., Neven P., Colombo N., Berteloot P., Mäenpää J., Olbrecht S., Laga T., Sablon E., Ray-Coquard I., Pujade-Lauraine E., Lambrechts D., Van Gorp T.
Publikováno v:
European Journal of Cancer. 188:131-139
Background: The PAOLA-1/ENGOT-ov25 trial showed improved progression-free (PFS) and overall survival (OS) in homologous recombination deficient (HRD) positive patients treated with olaparib, but not when HRD negative (HRD tested with MyChoice CDx PLU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1bebb5507e5fc841665cd1eced0e3a9
https://doi.org/10.1016/j.ejca.2023.04.020
https://doi.org/10.1016/j.ejca.2023.04.020
Autor:
Timmerman, S., Van Rompuy, A.S., Van Gorp, T., Vanden Bempt, I., Brems, H., Van Nieuwenhuysen, E., Han, S.N., Neven, P., Victoor, J., Laenen, A., Vergote, I.
Publikováno v:
In Gynecologic Oncology April 2020 157(1):245-251
Autor:
Steklov, M., Pandolfi, S., Baietti, M. F., Batiuk, A., Carai, P., Najm, P., Zhang, M., Jang, H., Renzi, F., Cai, Y., Asbagh, L. Abbasi, Pastor, T., De Troyer, M., Simicek, M., Radaelli, E., Brems, H., Legius, E., Tavernier, J., Gevaert, K., Impens, F., Messiaen, L., Nussinov, R., Heymans, S., Eyckerman, S., Sablina, A. A.
Publikováno v:
Science, 2018 Dec 01. 362(6419), 1177-1182.
Externí odkaz:
https://www.jstor.org/stable/26569198
Autor:
Smeijers S; Department of Neurosurgery, KU Leuven University Hospitals, Leuven, Belgium steven.smeijers@uzleuven.be., Brems H; Center for Human Genetics and Department of Human Genetics, KU Leuven University Hospitals, Leuven, Belgium., Verhaeghe A; Department of Neurosurgery, AZ Sint-Jan AV, Brugge, Belgium., van Paesschen W; Department of Neurology, KU Leuven University Hospitals, Leuven, Belgium., van Loon J; Department of Neurosurgery, KU Leuven University Hospitals, Leuven, Belgium., Van der Auweraer S; Center for Human Genetics and Department of Human Genetics, KU Leuven University Hospitals, Leuven, Belgium., Sciot R; Department of Pathology, KU Leuven University Hospitals, Leuven, Belgium., Thal DR; Department of Pathology, KU Leuven University Hospitals, Leuven, Belgium.; Laboratory for Neuropathology, Department of Imaging and Pathology and Leuven Brain Institute, KULeuven, Leuven, Belgium., Lagae L; Department of Paediatric Neurology, University of Leuven, Leuven, Belgium., Legius E; Center for Human Genetics and Department of Human Genetics, KU Leuven University Hospitals, Leuven, Belgium., Theys T; Department of Neurosurgery, KU Leuven University Hospitals, Leuven, Belgium.
Publikováno v:
Journal of medical genetics [J Med Genet] 2024 Aug 29; Vol. 61 (9), pp. 904-907. Date of Electronic Publication: 2024 Aug 29.
Autor:
Lovatt C; European Cancer Stem Cell Research Institute Cardiff University Cardiff UK., Williams M; European Cancer Stem Cell Research Institute Cardiff University Cardiff UK., Gibbs A; European Cancer Stem Cell Research Institute Cardiff University Cardiff UK., Mukhtar A; European Cancer Stem Cell Research Institute Cardiff University Cardiff UK., Morgan HJ; European Cancer Stem Cell Research Institute Cardiff University Cardiff UK., Lanfredini S; European Cancer Stem Cell Research Institute Cardiff University Cardiff UK., Olivero C; European Cancer Stem Cell Research Institute Cardiff University Cardiff UK., Spurlock G; Division of Cancer and Genetics Institute of Medical Genetics Cardiff University Cardiff UK., Davies S; Division of Cancer and Genetics Institute of Medical Genetics Cardiff University Cardiff UK., Philpott C; Division of Cancer and Genetics Institute of Medical Genetics Cardiff University Cardiff UK., Tovell H; Division of Cancer and Genetics Institute of Medical Genetics Cardiff University Cardiff UK., Turnpenny P; Clinical Genetics Royal Devon and Exeter NHS Foundation Trust Exeter UK., Baban D; Wellcome Trust Centre for Human Genetics Oxford UK., Knight S; Wellcome Trust Centre for Human Genetics Oxford UK., Brems H; Department of Human Genetics KU Leuven Leuven Belgium., Sampson JR; Division of Cancer and Genetics Institute of Medical Genetics Cardiff University Cardiff UK., Legius E; Department of Human Genetics KU Leuven Leuven Belgium., Upadhyaya M; Division of Cancer and Genetics Institute of Medical Genetics Cardiff University Cardiff UK., Patel GK; European Cancer Stem Cell Research Institute Cardiff University Cardiff UK.
Publikováno v:
Skin health and disease [Skin Health Dis] 2024 Jun 24; Vol. 4 (5), pp. e394. Date of Electronic Publication: 2024 Jun 24 (Print Publication: 2024).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gallon R; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. richard.gallon@newcastle.ac.uk., Brekelmans C; Centre for Human Genetics, University Hospital Leuven, Leuven, Belgium., Martin M; CHU, University of Liège, Liège, Belgium., Bours V; CHU, University of Liège, Liège, Belgium., Schamschula E; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Amberger A; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Muleris M; Département de Génétique, AP-HP.Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.; Inserm UMRS_938, Sorbonne Université, Centre de Recherche Saint Antoine, Paris, France., Colas C; Département de Génétique, Institut Curie, Paris, France.; INSERM U830, Université de Paris, Paris, France., Dekervel J; Department of Digestive Oncology, University Hospital Leuven, Leuven, Belgium., De Hertogh G; Department of Pathology, University Hospital Leuven, Leuven, Belgium., Coupier J; Human Genetics, CHU Liège, Liège, Belgium., Colleye O; Department of Pathology, CHU Liège, Liège, Belgium., Sepulchre E; CHU, University of Liège, Liège, Belgium., Burn J; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Brems H; Centre for Human Genetics, University Hospital Leuven, Leuven, Belgium., Legius E; Centre for Human Genetics, University Hospital Leuven, Leuven, Belgium., Wimmer K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria. katharina.wimmer@i-med.ac.at.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2024 May 24; Vol. 8 (1), pp. 119. Date of Electronic Publication: 2024 May 24.